🔎 Trials Near Me

Akèy › Kansè kol › Virginia › Arlington

Etid klinik pou Kansè kol nan Arlington, VA

16 etid pou Kansè kol ap chèche patisipan nan sit nan ak bò kote Arlington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

Ap rekriteFaz 3
  • Inova Schar Cancer Institute ( Site 5045), Fairfax · 11 mi lwen
Laj 18 ak plis · Fanm · Mizajou Sep 25, 2026 · NCT07216703

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Ap rekriteFaz 1
  • Virginia Cancer Specialists, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05983432

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Ap rekriteFaz 1/2
  • NEXT Oncology, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07109726

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Ap rekriteFaz 1
  • Virginia Cancer Specialists, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Ap rekriteFaz 1
  • NEXT Virginia, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07227168

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Ap rekriteFaz 1
  • Normunity Investigational Site, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07182149

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Clinical Trial Site, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07749586

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Ap rekriteFaz 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06330064

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

Ap rekrite
  • Inova Health System, Fairfax · 11 mi lwen
Laj 18 ak plis · Fanm · Mizajou Jul 30, 2026 · NCT04831580

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Ap rekriteFaz 1
  • NEXT Virginia, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07524322

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ap rekriteFaz 1
  • Virginia Cancer Specialists, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • NEXT, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT06993844

Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women

Ap rekrite
  • ISA Associates, Arlington
Laj 21 a 65 · Fanm · Mizajou Apr 21, 2026 · NCT07011836

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Ap rekriteFaz 1
  • Dren Investigational Site, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jan 7, 2026 · NCT06999187

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Research Site 102, Fairfax · 11 mi lwen
  • Research Site 112, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT05914116

Etid Kansè kol nan lòt vil

Lòt etid nan Arlington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.